Regenxbio develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome.
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
Cerecor is a clinical-stage biopharmaceutical company, which develops drugs to treat patients with neurological and psychiatric disorders.
CASI Pharmaceuticals focuses on building a pipeline through mutually beneficial business development transactions.
Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system.
CosmosID develops softwarefor identifyingpathogens present in clinical, environmental, and other research samples.
OriGene Technologies, a research tool company, provides a commercial collection of full-length human cDNAs.
SynAm Vaccine is a company aimed to eradicate pneumococcal diseases.
Fina Biosolutions is a research and development stage biotechnology company.